Here are four notes:
1. The transaction was valued at $90,207.
2. Mr. Phillips sold the shares at an average price of $23.10 per share.
3. He currently owns 11,557 Exactech shares.
4. On April 13, Robert W. Baird upgraded Exactech shares to an “outperform” rating.
More articles on devices:
4 trends in outpatient spine surgery from Amendia
InVivo Therapeutics adds Penn Medicine as INSPIRE study site: 4 points
DJO Global reports Q1 12.7% net sales growth, $38.3M net loss: 7 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
